Lucas Lopardi Franco

Lucas Lopardi Franco

Auto-generated profile, based on publicly available information

Lucas Lopardi Franco

Faculdade de Ciências Farmacêuticas Universidade Federal de Alfenas MG Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2024 in Critical Reviews in Analytical Chemistry
Verified
Journal Article
Closed access
CCCleydson Finotti Cordeiro
Cleydson Finotti Cordeiro
LFLucas Lopardi Franco
Lucas Lopardi Franco
Diogo Teixeira CarvalhoDiogo Teixeira Carvalho
Diogo Teixeira Carvalho
RBRudy Bonfilio
Rudy Bonfilio
The presence of impurities in active pharmaceutical ingredients (APIs) and drug products represents a risk to patients' health. Such substances are related to diverse side effects and may have mutagenic potential. That's why it is necessary to establish acceptable limits for these by-products, to minimize the risk associated with medicinal therapy. This work focused on presenting a critical review of relevant points related to the presence of impurities in pharmaceuticals. The main legislation and guidelines from the FDA, EMA, ICH, and Pharmacopeias about the subject were evaluated, and recent articles related to the topic were searched in Scopus, ScienceDirect, PubMed, and Web of Science from 2013 to 2023. Additionally, the analytical techniques used for quantifying impurities were discussed, along with relevant tests for assessing the toxicological and mutagenic risks of these by-products. Recent legislation, including ICH Q3A (R2), ICH Q3B (R2), ICH M7 (R2), ICH Q3D (R2), ICH Q3C (R9), ICH Q3E, ICH Q6A, ICH M3 (R2), as well as FDA and EMA guidelines, highlights a comprehensive and effective framework for controlling impurities in pharmaceuticals. Despite this, there remains a lack of harmonization and standardized procedures across different regions. From the review of scientific literature, we observed that advancements in analytical techniques have significantly improved the sensitivity and selectivity in detecting impurities and degradation products. This underscores the ongoing commitment of health agencies and the pharmaceutical industry to ensure the safety and efficacy of medicinal products.

16 August 2021 in Journal of Pharmacy & Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
MPMônica Fraccarolli Pelozo
Mônica Fraccarolli Pelozo
GLGiovanna Fiori Serpa Lima
Giovanna Fiori Serpa Lima
CCCleydson Finotti Cordeiro
Cleydson Finotti Cordeiro
LSLuana Sueli Silva
Luana Sueli Silva
ICIvo Santana Caldas
Ivo Santana Caldas
LFLucas Lopardi Franco
Lucas Lopardi Franco
Background: The search for new drug compounds is always challenging and there are several different strategies that involve the most varied and creative approaches in medicinal chemistry. One of them is the technique of molecular hybridisation: forming a hybrid compound from two or more pharmacophoric subunits. These hybrids may maintain the characteristics of the original compound and preferably show improvements to its pharmacological action, with reduced side effects and lower toxicity when compared to the original components. This study specifically focuses on synthesising hybrid molecules which demonstrate trypanocidal activity against the epimastigote and trypomastigote forms of Trypanosoma cruzi. Methods: In this context, this study centres on the synthesis of a novel structural scaffold via molecular hybridisation; by using a triazole species to link a metronidazole unit to a eugenol analogue unit, the objective being to combine their therapeutic properties into a new molecular structure. The resulting hybrid molecules were evaluated against T. cruzi which is responsible for high incidences of trypanosomiasis in tropical countries such as Brazil. Results: The results of this study showed an improvement in the anti-parasitic activity of the hybrid compounds with the best result coming from hybrid compounds [8] and [9], which present an activity similar to the control drug benznidazole. The new compounds, utilising a triazole species as a coupling connector, demonstrated promising results and has highlighted the path for planning similar structural patterns to investigate new compounds. Conclusions: In summary, we can conclude that the synthesised hybrid compounds demonstrate that using a triazole to link metronidazole with natural phenols, produces hybrid molecules that are promising as a new class of compounds of therapeutic interest for further investigation.

29 September 2023 in Microbial Pathogenesis
Verified
Journal Article
Closed access
ILIgor Rodrigues Lapa
Igor Rodrigues Lapa
FSFallon dos Santos Siqueira
Fallon dos Santos Siqueira
CCCleydson Finotti Cordeiro
Cleydson Finotti Cordeiro
MCMarli Matiko Anraku de Campos
Marli Matiko Anraku de Campos
RBRudy Bonfilio
Rudy Bonfilio
Diogo Teixeira CarvalhoDiogo Teixeira Carvalho
Diogo Teixeira Carvalho

29 April 2023 in Folia Microbiologica
Verified
Journal Article
Closed access
PDF file
LOLucas M. Oliveira
Lucas M. Oliveira
FSFallon S. Siqueira
Fallon S. Siqueira
MSMichelle T. Silva
Michelle T. Silva
JMJosé V. C. Machado
José V. C. Machado
CCCleydson F. Cordeiro
Cleydson F. Cordeiro
Diogo Teixeira CarvalhoDiogo Teixeira Carvalho
Diogo Teixeira Carvalho

15 March 2024 in Bioorganic Chemistry
Verified
Journal Article
Closed access
MPMônica Fraccarolli Pelozo
Mônica Fraccarolli Pelozo
CCCleydson Finotti Cordeiro
Cleydson Finotti Cordeiro
LILetícia Fonseca Inácio
Letícia Fonseca Inácio
RLRayssa de Cassia Alves Lemini
Rayssa de Cassia Alves Lemini
ELElda Gonçalves Souza e Leite
Elda Gonçalves Souza e Leite
LFLucas Lopardi Franco
Lucas Lopardi Franco

17 April 2025 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
DADalila Junqueira Alvarenga
Dalila Junqueira Alvarenga
PTPaulo José Silva de Toledo
Paulo José Silva de Toledo
JFJorys César Hegedus Filho
Jorys César Hegedus Filho
JCJoão Vitor de Souza Nascimento Cândido
João Vitor de Souza Nascimento Cândido
LFLucas Lopardi Franco
Lucas Lopardi Franco
Diogo Teixeira CarvalhoDiogo Teixeira Carvalho
Diogo Teixeira Carvalho